细胞因子信号抑制因子1
肝细胞癌
甲基化
肝硬化
癌症研究
DNA甲基化
表观遗传学
CpG站点
医学
细胞因子
细胞因子信号抑制因子
癌
抑癌基因
发起人
基因表达
SOCS3
基因
病理
抑制器
生物
内科学
癌症
癌变
遗传学
作者
Pei‐Yi Chu,Chung‐Min Yeh,Nicholas C. Hsu,Ya‐Sian Chang,Jan‐Gowth Chang,Kun‐Tu Yeh
出处
期刊:Schweizerische Medizinische Wochenschrift
日期:2010-07-15
被引量:44
标识
DOI:10.4414/smw.2010.13065
摘要
It has been postulated that the induced suppressor of cytokine signalling (SOCS) protein inhibits the signalling pathway through the association with a variety of tyrosine kinase proteins, and decelerates or inhibits the progression of cirrhosis and hepatocellular carcinoma (HCC). The purpose of this study was to investigate the expression of SOCS1 gene in HCC and explore the potential molecular mechanisms.We investigated CpG island methylation status at the promoter region and the expression of the SOCS1 gene in 46 HCC tumour and paired non-tumour samples.This immuno-histochemical study demonstrated strong homogeneous or heterogeneous staining in the non-tumour liver tissue compared to a marked decreased heterogeneous staining in the HCC (p 0.001). Real-time quantitative (qRT)-PCR showed that SOCS1 mRNA was also down-regulated in tumour cells of HCC. The methylation analysis of CpG sites at the promoter region of SOCS1 disclosed hypermethylation in 39% of HCC samples and 41% of non-tumour tissue. Promoter methylation of SOCS1 was well correlated with HCC derived from liver cirrhosis (p = 0.044) and tumour size (p = 0.038).Our findings suggest a tumour suppressor-like role of SOCS1 in the hepatocarcinogenesis of human HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI